JUN 03, 2020 8:41 PM PDT

A Drug That Deletes Cravings?

WRITTEN BY: Nouran Amin

No More Cravings?

Scientists at Duke University may have created a drug to hone cravings and possibly help with weight management. They specifically synthesized a molecule that ‘calms-down’ the physiological responses of cocaine in mice. The synthesized molecule, called SBI-553, activates cell surface chemical receptors known as G protein-coupled receptors or GPCRs. These receptors are the target of more than 35% of all FDA-approved drugs.

Learn more behind the science of cravings:

"This kind of idea has been kicking around for 20 years or so," adds senior author Marc Caron, whose work was based on GPCR signaling.

Researchers found that one specific GPCR known as ‘neurotensin receptor 1 (NTSR1)’ as a way to alter the actions of stimulant drugs.

Findings were published in the journal Cell and describes how mouse studies show that neurotensin is involved in drug-seeking behavior and food intake.

"It regulates the brain's reward system and motivated behavior," said senior post-doctoral fellow Lauren Slosky, who is the lead author on the paper. "The current findings suggest that the selective activation of the NTSR1 beta-arrestin response is sufficient to produce some of the anti-addiction effects attributed to the NTSR1, but not its effects on blood pressure and body temperature."

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 25, 2022
Microbiology
How a Serious Infection Can Cause Mood Disorders
APR 25, 2022
How a Serious Infection Can Cause Mood Disorders
When a pathogen invades the body, the immune system has to mount a response, which involves inflammation. But inflammati ...
JUN 06, 2022
Drug Discovery & Development
Express Media Service Q&A with Sheng Li, PhD., FUJIFILM Irvine Scientific
JUN 06, 2022
Express Media Service Q&A with Sheng Li, PhD., FUJIFILM Irvine Scientific
FUJIFILM Irvine Scientific sat down with Sheng Li, PhD, Program Manager, to speak about our rapid service for small-scal ...
MAY 25, 2022
Neuroscience
Exploring Drug Targets in Neurodegenerative Diseases
MAY 25, 2022
Exploring Drug Targets in Neurodegenerative Diseases
Introduction Life expectancy has increased globally over the last several decades. However, longer life expectancy comes ...
JUN 02, 2022
Cancer
Call to Diversify Clinical Trials
JUN 02, 2022
Call to Diversify Clinical Trials
Clinical Trials represent an integral component of biomedical research.  These research studies utilize human subje ...
JUN 06, 2022
Microbiology
Light-Activated Nanoscale Drills Can Penetrate Bacteria
JUN 06, 2022
Light-Activated Nanoscale Drills Can Penetrate Bacteria
In 1999, a miniature rotor that could be moved reliably was attached to a molecule. Researchers have come a long way sin ...
JUN 19, 2022
Drug Discovery & Development
Math Model Predicts Anti-inflammatory Drug Efficacy Post-heart Attack
JUN 19, 2022
Math Model Predicts Anti-inflammatory Drug Efficacy Post-heart Attack
Researchers created a mathematical model that can predict drug combinations that may one day help treat heart attacks. T ...
Loading Comments...